PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER‐RISK MYELODYSPLASTIC SYNDROMES
Zeidan A, Divino V, DeKoven M, Shah D, Wang E, Bey D, Salimi T, Epstein R. PB1923: PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH HYPOMETHYLATING AGENT USE IN HIGHER‐RISK MYELODYSPLASTIC SYNDROMES. HemaSphere 2022, 6: 1802-1803. PMCID: PMC9431607, DOI: 10.1097/01.hs9.0000850544.77658.8d.Peer-Reviewed Original Research